Synlogic, Inc. 0A8U.L Stock
Synlogic, Inc. Price Chart
Synlogic, Inc. 0A8U.L Financial and Trading Overview
Synlogic, Inc. stock price | 1.7 USD |
Previous Close | 0.6 USD |
Open | 0 USD |
Bid | 0 USD x N/A |
Ask | 0 USD x N/A |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 1.3 USD |
Volume | 53.2K USD |
Avg. Volume | 4.26K USD |
Market Cap | N/A |
Beta (5Y Monthly) | 1.026056 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.974 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0A8U.L Valuation Measures
Enterprise Value | 4.7M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.62079203 |
Enterprise Value/Revenue | 4.236 |
Enterprise Value/EBITDA | -0.072 |
Trading Information
Synlogic, Inc. Stock Price History
Beta (5Y Monthly) | 1.026056 |
52-Week Change | -41.66% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.3 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 0.83 USD |
200-Day Moving Average | 0.83 USD |
0A8U.L Share Statistics
Avg. Volume (3 month) | 4.26K USD |
Avg. Daily Volume (10-Days) | 3.16K USD |
Shares Outstanding | N/A |
Float | 46.76M |
Short Ratio | N/A |
% Held by Insiders | 16.63% |
% Held by Institutions | 51.31% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -6116.84% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -33.57% |
Return on Equity (ttm) | -65.74% |
Income Statement
Revenue (ttm) | 1.11M USD |
Revenue Per Share (ttm) | 0.02 USD |
Quarterly Revenue Growth (yoy) | -28.69% |
Gross Profit (ttm) | 1.18M USD |
EBITDA | -65402000 USD |
Net Income Avi to Common (ttm) | -66072000 USD |
Diluted EPS (ttm) | -0.974 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 57.37M USD |
Total Cash Per Share (mrq) | 0.84 USD |
Total Debt (mrq) | 19.3M USD |
Total Debt/Equity (mrq) | 28.09 USD |
Current Ratio (mrq) | 6.404 |
Book Value Per Share (mrq) | 1.01 |
Cash Flow Statement
Operating Cash Flow (ttm) | -62916000 USD |
Levered Free Cash Flow (ttm) | -37921876 USD |
Profile of Synlogic, Inc.
Country | United Kingdom |
State | MA |
City | Cambridge |
Address | 301 Binney Street |
ZIP | 02142 |
Phone | 617 401 9975 |
Website | https://www.synlogictx.com |
Industry | |
Sector(s) | |
Full Time Employees | 72 |
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic and immunological diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase II clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.
Q&A For Synlogic, Inc. Stock
What is a current 0A8U.L stock price?
Synlogic, Inc. 0A8U.L stock price today per share is 1.7 USD.
How to purchase Synlogic, Inc. stock?
You can buy 0A8U.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Synlogic, Inc.?
The stock symbol or ticker of Synlogic, Inc. is 0A8U.L.
How many shares does Synlogic, Inc. have in circulation?
The max supply of Synlogic, Inc. shares is 0.
What is Synlogic, Inc. Price to Earnings Ratio (PE Ratio)?
Synlogic, Inc. PE Ratio is now.
What was Synlogic, Inc. earnings per share over the trailing 12 months (TTM)?
Synlogic, Inc. EPS is -0.974 USD over the trailing 12 months.